Cathie Wood acquired 9.51 Million Intellia Therapeutics shares worth $604 Million. That's 3.26% of their equity portfolio (10th largest holding). The investor owns 12.17% of the outstanding Intellia Therapeutics stock. The first Intellia Therapeutics trade was made in Q4 2016. Since then Cathie Wood bought shares sixteen more times and sold shares on four occasions. The stake costed the investor $332 Million, netting the investor a gain of 82% so far.